Literature DB >> 15070899

Biochemical and functional analysis of smallpox growth factor (SPGF) and anti-SPGF monoclonal antibodies.

Mikyung Kim1, Hailin Yang, Sung-Kwon Kim, Pedro A Reche, Rebecca S Tirabassi, Rebecca E Hussey, Yasmin Chishti, James G Rheinwald, Tiara J Morehead, Tobias Zech, Inger K Damon, Raymond M Welsh, Ellis L Reinherz.   

Abstract

Variola, the causative agent of smallpox, is a highly infectious double-stranded DNA virus of the orthopox genus that replicates within the cytoplasm of infected cells. For unknown reasons prominent skin manifestations, including "pox," mark the course of this systemic human disease. Here we characterized smallpox growth factor (SPGF), a protein containing an epidermal growth factor (EGF)-like domain that is conserved among orthopox viral genomes, and investigated its possible mechanistic link. We show that after recombinant expression, refolding, and purification, the EGF domain of SPGF binds exclusively to the broadly expressed cellular receptor, erb-B1 (EGF receptor), with subnanomolar affinity, stimulating the growth of primary human keratinocytes and fibroblasts. High affinity monoclonal antibodies specific for SPGF reveal in vivo immunoprotection in a murine vaccinia pneumonia model by a mechanism distinct from viral neutralization. These findings suggest that blockade of pathogenic factor actions, in general, may be advantageous to the infected host.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15070899     DOI: 10.1074/jbc.M400343200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Smallpox: an ancient disease enters the modern era of virogenomics.

Authors:  Grant McFadden
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-12       Impact factor: 11.205

2.  Antiviral chemotherapy facilitates control of poxvirus infections through inhibition of cellular signal transduction.

Authors:  Hailin Yang; Sung-Kwon Kim; Mikyung Kim; Pedro A Reche; Tiara J Morehead; Inger K Damon; Raymond M Welsh; Ellis L Reinherz
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

3.  The C11R gene, which encodes the vaccinia virus growth factor, is partially responsible for MVA-induced NF-κB and ERK2 activation.

Authors:  Stefani Martin; Daniel T Harris; Joanna Shisler
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

4.  Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge.

Authors:  Shlomo Lustig; Christiana Fogg; J Charles Whitbeck; Roselyn J Eisenberg; Gary H Cohen; Bernard Moss
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

5.  The host response to smallpox: analysis of the gene expression program in peripheral blood cells in a nonhuman primate model.

Authors:  Kathleen H Rubins; Lisa E Hensley; Peter B Jahrling; Adeline R Whitney; Thomas W Geisbert; John W Huggins; Art Owen; James W Leduc; Patrick O Brown; David A Relman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-11       Impact factor: 11.205

6.  SOCS-1 mimetics protect mice against lethal poxvirus infection: identification of a novel endogenous antiviral system.

Authors:  Chulbul M Ahmed; Rea Dabelic; Lilian W Waiboci; Lindsey D Jager; Linda L Heron; Howard M Johnson
Journal:  J Virol       Date:  2008-11-19       Impact factor: 5.103

7.  Vaccinia virus entry, exit, and interaction with differentiated human airway epithelia.

Authors:  Paola D Vermeer; Julia McHugh; Tatiana Rokhlina; Daniel W Vermeer; Joseph Zabner; Michael J Welsh
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

8.  The tanapoxvirus 15L protein is a virus-encoded neuregulin that promotes viral replication in human endothelial cells.

Authors:  David Jeng; Zhenzhong Ma; John W Barrett; Grant McFadden; Jeffrey A Loeb; Karim Essani
Journal:  J Virol       Date:  2012-12-26       Impact factor: 5.103

9.  Major neutralizing sites on vaccinia virus glycoprotein B5 are exposed differently on variola virus ortholog B6.

Authors:  Lydia Aldaz-Carroll; Yuhong Xiao; J Charles Whitbeck; Manuel Ponce de Leon; Huan Lou; Mikyung Kim; Jessica Yu; Ellis L Reinherz; Stuart N Isaacs; Roselyn J Eisenberg; Gary H Cohen
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

10.  The highly virulent variola and monkeypox viruses express secreted inhibitors of type I interferon.

Authors:  María del Mar Fernández de Marco; Alí Alejo; Paul Hudson; Inger K Damon; Antonio Alcami
Journal:  FASEB J       Date:  2009-12-17       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.